Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Kuzik, S. Al Qadhi, S. Kent, M. Flavin, S. Hotte, S. Gander (Barrie, ON, Toronto, ON, Victoria, BC, Kingston, ON, Canada). Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. Eur Respir J 2007; 30: Suppl. 51, 3011

Member's Comments

No comment yet.

Related content which might interest you: Nebulised hypertonic saline in the treatment of viral bronchiolitis in infants Source: ISSN=ISSN 1810-6838, ISBN=, page=160 Year: 2007 Effect of inhaled hypertonic saline solution to treat infants hospitalized with viral bronchiolitis Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011 Efficacy of hypertonic saline solution in infant with acute bronchiolitis Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007 Nebulized 3% hypertonic saline in the treatment of acute bronchiolitis in infants Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Hypertonic saline for acute viral bronchiolitis: take the evidence with a grain of salt Source: Eur Respir J 2014; 44: 827-830 Year: 2014 Nebulized saline treatment in patients with concomitant asthma and bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 7% hypertonic saline and hyaluronic acid and in the treatment of infants mild-moderate bronchiolitis Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011 Effects of nebulizer therapy by hypertonic saline, gender and breastfeeding on evolution of acute bronchiolitis Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Inhaled fraction and granulometry of hypertonic saline solution Aerosol for the ambulatory management of newborn babies with viral bronchiolitis: size matters. Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018 Hypertonic saline and acute wheezing in pre-school children Source: Annual Congress 2012 - Treating childhood asthma Year: 2012 Do infants with bronchiolitis get any benefit with nebulized salbutamol? Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy Year: 2011 Effectiveness of nebulised hypertonic saline on the respiratory management of children and young people with neuromuscular disease Source: International Congress 2019 – Innovations in care for chronic respiratory conditions Year: 2019 Clinical surveys with nebulised hypertonic saline (HS) in CF children Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 Comparison of treatments with nebulised salbutamol and epinephrine in acute bronchiolitis Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004 Hypertonic saline in children with bronchiolitis Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Is 5% saline safe and effective for acute bronchiolitis Source: Breathe 2010; 7: 198-199 Year: 2010 Instillation of surfactant-BL is more effective than aerosol administration in treatment of premature newborns with severe RDS Source: Eur Respir J 2002; 20: Suppl. 38, 532s Year: 2002 Montelukast attenuates the airway response to hypertonic saline in patients with moderate to severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 189s Year: 2002 Comparison of magnesium sulfate to normal saline as a vehicle for nebulized salbutamol in children with acute asthma; a clinical trial Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives Year: 2008 Is nebulized saline a placebo in COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 184s Year: 2001